Massachusetts · 194th Legislature (2025-2026) · Bill
S 2035: An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 2035 is a bill introduced in the Massachusetts Senate on February 27, 2025. According to its official title, it concerns: An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing. Primary sponsor: Jason Lewis (Democratic). It lists 1 additional sponsor. Most recent recorded action (July 23, 2026): Accompanied a study order, see H5596.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
By Mr. Lewis, a petition (accompanied by bill, Senate, No. 2035) of Jason M. Lewis and Rebecca L. Rausch for legislation to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing. Revenue.
Sponsors
Sponsors by party (alphabetical): Democratic 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Jason Lewis | Primary sponsor | Democratic | Senate | Fifth Middlesex |
| Becca Rausch | Co-sponsor | Democratic | Senate | Norfolk, Worcester and Middlesex |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Accompanied a study order, see H5596
- Reporting date extended to Thursday June 25, 2026
- Hearing scheduled for 10/28/2025 from 01:00 PM-05:00 PM in B-2
- House concurred
- Referred to the committee on Revenue